Venrock Healthcare Capital Partners II, L.P. 13D and 13G filings for TRICIDA INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-10-28 4:05 pm Sale | 2022-10-25 | 13G | TRICIDA INC TCDAQ | Venrock Healthcare Capital Partners II, L.P. | 2,982,528 5.400% | -5,899,349![]() (-66.42%) | Filing |
2022-09-28 9:20 pm Purchase | 2022-09-26 | 13G | TRICIDA INC TCDAQ | Venrock Healthcare Capital Partners II, L.P. | 8,881,877 16.000% | 3,016,717![]() (+51.43%) | Filing |
2022-06-06 5:31 pm Purchase | 2022-06-01 | 13G | TRICIDA INC TCDAQ | Venrock Healthcare Capital Partners II, L.P. | 5,865,160 10.600% | 2,370,309![]() (+67.82%) | Filing |
2022-02-14 4:19 pm Purchase | 2021-11-17 | 13G | TRICIDA INC TCDAQ | Venrock Healthcare Capital Partners II, L.P. | 3,494,851 6.300% | 3,494,851![]() (New Position) | Filing |